Catalyst Wire Dossier Catalyst Wire Dossier

5LGr

· Tasly Pharmaceuticals, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for 5LGr, covering 2012-12-12 to 2012-12-12. Get the full timeline:

Most recent: Clinical Trial Update: Phase III Study of 5LGr to Treat Tic Disorder [Phase 3]

See pricing